ALL SESSIONS

Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immuno-therapies

Antibody Drug Conjugates

Antibody-Drug Conjugates

Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immuno-therapies

Antibody Drug Conjugates

Antibody-Drug Conjugates

Industry Sponsored

View Sessions

UPCOMING

Join us for
our roundtable in
||
latest advances in
||
your questions on
||
new therapies for
||
practice changes in
||
your patient cases in

LUNG CANCER — The Year In Review

Charles Rudin

USA

Solange Peters

Switzerland

Martin Reck

Germany

Agenda & Discussion Topics

DRUGGABLE SINCE 2025: New Approvals and Emerging Options

Solange Peters

The Year of SCLC: From hope to practice

Charles Rudin

Highlights in Targeted Therapies and ADCs

Martin Reck
ï•™

2 CME Points

EACCME® & SGMO

Join our host, Solange Peters, for our Virtual Lung Summit on the newest advances in lung cancer care. This interdisciplinary session brings together leading experts to synthesize the most important findings of the past year and translate them into practical, real-world strategies. We’ll explore newly approved therapies, key updates in targeted treatments, and the evolving role of immunotherapy across NSCLC and SCLC. Don’t miss this opportunity to deepen your understanding, take part in the discussion, and come away with clear takeaways on the developments reshaping lung cancer treatment.
Register here

Do You Already Have An Account?
No need to sign up again: as a verified user, you will have access to all our sessions. Simply login to participate in this event.


First Time On Lung Summit?

SIGN UP NOW

This session is kindly supported by our partners with no influence on the content

Amgen
AstraZeneca
BeOne
Roche
PharmaMar
MSD

ILCS 2025

International Lung Cancer Summit 2025

ADD THIS TO YOUR CALENDAR

Following the success of the previous International Lung Cancer Summits (ILCS), we warmly invite you to the 7th edition, expertly chaired by the distinguished duo Solange Peters and Alfredo Addeo. This premier hybrid conference continues its tradition of excellence by highlighting the latest breakthroughs in lung cancer treatment. With a global lineup of renowned speakers from the USA, France, UK, Spain, Ireland, Italy, Australia, Singapore, and Switzerland, the ILCS provides a unique platform for professionals from clinics, universities, and research institutes to engage, network, and collaborate. By leveraging digital platforms, the summit fosters a dynamic environment for sharing insights and advancing lung cancer care.

CHUV-HUG Logo
ISREC
IASLC
ETOP
OncoViews

LED BY GLOBAL EXPERTS

Marius Ilié

France

Antonio Passaro

Italy

Antonio Calles

Spain

Xiuning Le

USA

Andrea Filippi

Italy

Noemi Reguart

Spain

Tom John

Australia

Alessandra Curioni

Switzerland

Patrick Forde

Ireland

Stephanie Saw

Singapore

Thomas Newsom-Davis

United Kingdom

Rami Manochakian

USA

ADD THIS TO YOUR CALENDAR

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates